Abstract
Geographically, multiple sclerosis (MS) seems to be distributed into three zones of high, medium, and low frequency. High-frequency areas, with prevalence rates over 30 per 100,000 population, include Europe between 65° and 45° north latitude, southern Canada and the northern United States, and New Zealand and southern Australia. These regions are bounded by areas of medium frequency with prevalence rates of 5 to 25 per 100,000, which include southern Europe, the southern United States, and most of Australia. Known areas of Asia and Africa (save for one white group in South Africa) are all low, with prevalence rates under 5 per 100,000 population.
All high- and medium-risk areas are among predominantly white populations: In America, blacks and Orientals have much lower rates of MS than whites but still demonstrate the geographic gradients found for whites. Migration studies indicate that on the whole, migrants retain much of the risk of their birthplace. However, this risk is clearly not defined at birth: MS death rates for migrants born in one risk area and dying in another are intermediate between the rates characteristic of their birthplaces. Prevalence studies for migrants from high- to low-risk areas indicate the age of adolescence to be critical for risk retention; those migrating under age 15 years acquire the lower risk of their new residence. Furthermore, several low-to-high studies show that those migrating in childhood or adolescence increase the risk of MS.
The migrant data, plus the geographic distributions, serve to define MS as an acquired, exogenous (environmental) disease whose acquisition in ordinary circumstances takes place years before clinical onset. The data fit best the “simple” or “prevalence” hypothesis: that the cause of MS will be found where the clinical disease is common. Further evidence for this viewpoint is provided by the occurrence of two epidemics of MS: one (definite) in the Faroe Islands, the other (probable) in Iceland. Both followed the occupation of those lands by British forces during World War II. If this relation is causal, MS is not only acquired but also transmittable.
- © 1980 by the American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
